Proteome Profile of Peripheral Myelin in Healthy Mice and in a Neuropathy
Total Page：16
File Type：pdf, Size：1020Kb
TOOLS AND RESOURCES Proteome profile of peripheral myelin in healthy mice and in a neuropathy model Sophie B Siems1†, Olaf Jahn2†, Maria A Eichel1, Nirmal Kannaiyan3, Lai Man N Wu4, Diane L Sherman4, Kathrin Kusch1, Do¨ rte Hesse2, Ramona B Jung1, Robert Fledrich1,5, Michael W Sereda1,6, Moritz J Rossner3, Peter J Brophy4, Hauke B Werner1* 1Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Go¨ ttingen, Germany; 2Proteomics Group, Max Planck Institute of Experimental Medicine, Go¨ ttingen, Germany; 3Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany; 4Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom; 5Institute of Anatomy, University of Leipzig, Leipzig, Germany; 6Department of Clinical Neurophysiology, University Medical Center, Go¨ ttingen, Germany Abstract Proteome and transcriptome analyses aim at comprehending the molecular profiles of the brain, its cell-types and subcellular compartments including myelin. Despite the relevance of the peripheral nervous system for normal sensory and motor capabilities, analogous approaches to peripheral nerves and peripheral myelin have fallen behind evolving technical standards. Here we assess the peripheral myelin proteome by gel-free, label-free mass-spectrometry for deep quantitative coverage. Integration with RNA-Sequencing-based developmental mRNA-abundance profiles and neuropathy disease genes illustrates the utility of this resource. Notably, the periaxin- deficient mouse model of the neuropathy Charcot-Marie-Tooth 4F displays a highly pathological myelin proteome profile, exemplified by the discovery of reduced levels of the monocarboxylate *For correspondence: transporter MCT1/SLC16A1 as a novel facet of the neuropathology. This work provides the most [email protected] comprehensive proteome resource thus far to approach development, function and pathology of †These authors contributed peripheral myelin, and a straightforward, accurate and sensitive workflow to address myelin equally to this work diversity in health and disease. Competing interests: The authors declare that no competing interests exist. Introduction Funding: See page 22 The ensheathment of axons with myelin enables rapid impulse propagation, a prerequisite for nor- Received: 27 August 2019 mal motor and sensory capabilities of vertebrates (Weil et al., 2018; Hartline and Colman, 2007). Accepted: 19 February 2020 This is illustrated by demyelinating neuropathies of the Charcot-Marie-Tooth (CMT) spectrum, in Published: 04 March 2020 which mutations affecting myelin genes as MPZ, PMP22, GJB1 and PRX impair myelin integrity and reduce the velocity of nerve conduction in the peripheral nervous system (PNS) (Rossor et al., Reviewing editor: Beth Stevens, Boston Children’s Hospital, 2013). Developmentally, myelination by Schwann cells in peripheral nerves is regulated by axonal United States neuregulin-1 (Michailov et al., 2004; Taveggia et al., 2005) and the basal lamina (Chernousov et al., 2008; Petersen et al., 2015; Ghidinelli et al., 2017) that is molecularly linked Copyright Siems et al. This to the abaxonal Schwann cell membrane via integrins and the dystroglycan complex article is distributed under the (Sherman et al., 2001; Masaki et al., 2002; Nodari et al., 2008; Raasakka et al., 2019). In adult- terms of the Creative Commons Attribution License, which hood, the basal lamina continues to enclose all axon/myelin-units (Hess and Lansing, 1953), proba- permits unrestricted use and bly to maintain myelin. Beyond regulation by extracellular cues, myelination involves multiple redistribution provided that the proteins mediating radial sorting of axons out of Remak bundles, myelin membrane growth and original author and source are layer compaction (Sherman and Brophy, 2005; Pereira et al., 2012; Grove and Brophy, 2014; credited. Monk et al., 2015; Feltri et al., 2016). For example, the Ig-domain containing myelin protein zero Siems et al. eLife 2020;9:e51406. DOI: https://doi.org/10.7554/eLife.51406 1 of 31 Tools and resources Neuroscience (MPZ; also termed P0) mediates adhesion between adjacent extracellular membrane surfaces in compact myelin (Giese et al., 1992). At their intracellular surfaces, myelin membranes are com- pacted by the cytosolic domain of MPZ/P0 together with myelin basic protein (MBP; previously termed P1) (Martini et al., 1995; Nawaz et al., 2013). Not surprisingly, MPZ/P0 and MBP were early identified as the most abundant peripheral myelin proteins (Greenfield et al., 1973; Brostoff et al., 1975). A system of cytoplasmic channels through the otherwise compacted myelin sheath remains non- compacted throughout life, that is the adaxonal myelin layer, paranodal loops, Schmidt-Lanterman incisures (SLI), and abaxonal longitudinal and transverse bands of cytoplasm termed bands of Cajal (Sherman and Brophy, 2005; Nave and Werner, 2014; Kleopa and Sargiannidou, 2015). Non- compacted myelin comprises cytoplasm, cytoskeletal elements, vesicles and lipid-modifying enzymes, and thus numerous proteins involved in maintaining the myelin sheath. The cytosolic chan- nels probably also represent transport routes toward Schwann cell-dependent metabolic support of myelinated axons (Court et al., 2004; Beirowski et al., 2014; Dome`nech-Este´vez et al., 2015; Kim et al., 2016; Gonc¸alves et al., 2017; Stassart et al., 2018). Considering that Schwann cells constitute a major proportion of the cells in the PNS, oligonucleo- tide microarray analyses have been used for mRNA abundance profiling of total sciatic nerves (Nagarajan et al., 2002; Le et al., 2005). Indeed, these systematic approaches allowed the identifi- cation of novel myelin constituents including non-compact myelin-associated protein (NCMAP/ MP11) (Ryu et al., 2008). Notwithstanding that the number of known peripheral myelin proteins has grown in recent years, a comprehensive molecular inventory has been difficult to achieve because applications of systematic (‘omics’) approaches specifically to Schwann cells and peripheral myelin remained comparatively scarce, different from studies addressing oligodendrocytes and CNS myelin (Zhang et al., 2014; Patzig et al., 2016b; Sharma et al., 2015; Thakurela et al., 2016; Marques et al., 2016; de Monasterio-Schrader et al., 2012). One main reason may be that the available techniques were not sufficiently straightforward for general application. For example, the protein composition of peripheral myelin was previously assessed by proteome analysis (Patzig et al., 2011). However, at that time the workflow of sample preparation and data acquisition (schematically depicted in Figure 1A) was very labor-intense and required a substantial amount of input material; yet the depth of the resulting datasets remained limited. In particular, differential myelin proteome analysis by 2-dimensional fluorescence intensity gel electrophoresis (2D-DIGE) requires considerable hands-on-time and technical expertise (Patzig et al., 2011; Kangas et al., 2016). While this method is powerful for the separation of proteoforms (Kusch et al., 2017), it typi- cally suffers from under-representation of highly basic and transmembrane proteins. It thus allows comparing the abundance of only few myelin proteins rather than quantitatively covering the entire myelin proteome. Because of these limitations and an only modest sample-to-sample reproducibility, 2D-DIGE analysis of myelin, although unbiased, has not been commonly applied beyond specialized laboratories. The aim of the present study was to establish a straightforward and readily applicable workflow to facilitate both comprehensive knowledge about the protein composition of peripheral myelin and systematic assessment of differences between two states, for example, pathological alterations in a neuropathy model. The major prerequisites were the biochemical purification of myelin, its solubiliza- tion with the detergent ASB-14 and the subsequent automated digestion with trypsin during filter- aided sample preparation (FASP). The tryptic peptides were fractionated by liquid chromatography and analyzed by mass spectrometry for gel-free, label-free quantitative proteome analysis. More specifically, we used nano-flow ultra-performance liquid chromatography (nanoUPLC) coupled to an electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometer with ion mobility option, providing an orthogonal dimension of peptide separation. The utilized data-independent acquisition (DIA) strategy relies on collecting data in an alternating low and elevated energy mode (MSE); it enables simultaneous sequencing and quantification of all peptides entering the mass spec- trometer without prior precursor selection, as reviewed in Neilson et al. (2011) and Distler et al. (2014a). With their high-duty cycle utilized for the acquisition of precursor ions, MSE-type methods are ideally suited to reliably quantify proteins based on peptide intensities. Notably, these methods do not involve the use of spectral libraries in the identification of proteins, different from other DIA strategies. Instead, the achieved high-complexity fragmentation spectra are deconvoluted before submission to dedicated search engines for peptide and protein identification (Geromanos et al., Siems et al. eLife 2020;9:e51406. DOI: https://doi.org/10.7554/eLife.51406 2 of 31 Tools and resources Neuroscience A ^ĂŵƉůĞƉƌĞƉĂƌĂƟŽŶ WƌŽƚĞŝŶƐĞƉĂƌĂƟŽŶ dƌLJƉƐŝŶĚŝŐĞƐƟŽŶ WĞƉƟĚĞƐĞƉĂƌĂƟŽŶ DĂƐƐƐƉĞĐƚƌŽŵĞƚĞƌ ĂƚĂĂĐƋƵŝƐŝƟŽŶ Analysis output WƌĞĐŝƉŝƚĂƟŽŶ